Sydney Pharmacy School, Faculty of Medicine and Health, The University of Sydney, Camperdown, Australia.
Departments of Clinical Pharmacology and Aged Care, Kolling Institute of Medical Research, St Leonards, Australia.
Expert Rev Clin Pharmacol. 2020 Mar;13(3):233-245. doi: 10.1080/17512433.2020.1730812. Epub 2020 Feb 27.
: There is increasing recognition of the need for deprescribing of inappropriate medications in older adults. However, efforts to encourage implementation of deprescribing in clinical practice have resulted in mixed results across settings and countries.: Searches were conducted in PubMed, Embase, and Google Scholar in June 2019. Reference lists, citation checking, and personal reference libraries were also utilized. Studies capturing the main challenges of, and opportunities for, implementing deprescribing into clinical practice across selected health-care settings internationally, and international deprescribing-orientated policies were included and summarized in this narrative review.: Deprescribing intervention studies are inherently heterogeneous because of the complexity of interventions employed and often do not reflect the real-world. Further research investigating enhanced implementation of deprescribing into clinical practice and across health-care settings is required. Process evaluations in deprescribing intervention studies are needed to determine the contextual factors that are important to the translation of the interventions in the real-world. Deprescribing interventions may need to be individually tailored to target the unique barriers and opportunities to deprescribing in different clinical settings. Introduction of national policies to encourage deprescribing may be beneficial, but need to be evaluated to determine if there are any unintended consequences.
越来越多的人认识到需要减少老年人使用不当药物。然而,鼓励在临床实践中实施减少用药的努力在不同的环境和国家产生了不同的结果。
2019 年 6 月,我们在 PubMed、Embase 和 Google Scholar 上进行了检索。还利用了参考文献列表、引文检查和个人参考文献库。本叙述性综述纳入并总结了在国际上选定的医疗保健环境中实施减少用药的主要挑战和机遇的描述性研究,以及针对减少用药的国际政策。
由于所采用的干预措施的复杂性,减少用药的干预研究本质上具有异质性,而且往往不能反映现实情况。需要进一步研究,以增强减少用药在临床实践和整个医疗保健环境中的实施。需要对减少用药干预研究进行过程评估,以确定对干预措施在现实世界中的转化至关重要的背景因素。减少用药干预措施可能需要根据不同的临床环境进行个性化定制,以针对独特的障碍和机会。引入鼓励减少用药的国家政策可能是有益的,但需要进行评估,以确定是否有任何意外后果。